Home/YD Bio/Ethan Shen, PhD
ES

Ethan Shen, PhD

Chairman & CEO

YD Bio

Therapeutic Areas

YD Bio Pipeline

DrugIndicationPhase
DNA Methylation Cancer DetectionEarly Cancer Detection & MonitoringClinical Validation/Service Launch
Exosome-Based Ocular TherapeuticComplex Ocular Surface ConditionsPreclinical/Research
Dry Eye Care PortfolioDry Eye DiseaseCommercial
Clinical Trial SupplyN/A (Service)Commercial